FWP 1 dp09634_fwp-ps633.htm
 
 
 
 
May 2008
 
Preliminary Terms No. 633
Registration Statement No. 333-131266
Dated April 23, 2008
Filed pursuant to Rule 433
STRUCTURED INVESTMENTS
Opportunities in Equities
 
PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM
PLUS offer leveraged exposure to a wide variety of assets and asset classes, including equities, commodities and currencies.  These investments allow investors to capture enhanced returns relative to the assets actual positive performance.  The leverage typically applies only for a certain range of price performance.  In exchange for enhanced performance in that range, investors generally forgo performance above a specified maximum return.  At maturity, an investor will receive an amount in cash that may be more or less than the principal amount based upon the closing value of the asset at maturity.
SUMMARY TERMS
 
Issuer:
Morgan Stanley
Maturity date:
June 20, 2009
Underlying shares:
Shares of the iShares® MSCI Emerging Markets Index Fund
Aggregate principal amount:
$
Payment at maturity:
§ If final share price is greater than initial share price,
 
$10 + leveraged upside payment
 
In no event will the payment at maturity exceed the maximum payment at maturity.
 
§ If final share price is less than or equal to initial share price,
 
$10 x share performance factor
 
This amount will be less than or equal to the stated principal amount of $10.
Leveraged upside payment:
$10 x leverage factor x share percent increase
Leverage factor:
300%
Share percent increase:
(final share price – initial share price) / initial share price
Initial share price:
The closing price of one share of the underlying shares on the pricing date
Final share price:
The closing price of one share of the underlying shares on the valuation date times the adjustment factor
Maximum payment at maturity:
$12.60 to $12.80 (126% to 128% of the stated principal amount)
Share performance factor:
(final share price / initial share price)
Stated principal amount:
$10
Issue price:
$10 (see “Commissions and Issue Price” below)
Pricing date:
May      , 2008
Original issue date:
May      , 2008 (5 business days after the pricing date)
Valuation date:
June 18, 2009, subject to adjustment for certain market disruption events
Adjustment factor:
1.0, subject to adjustment in the event of certain events affecting the underlying shares
CUSIP:
617480322
Listing:
The PLUS will not be listed on any securities exchange.
Agent:
Morgan Stanley & Co. Incorporated
Commissions and Issue Price:
Price to Public(1)
Agent’s Commissions(1)(2)
Proceeds to Company
Per PLUS:
$10
$0.15
$9.85
Total:
$
$
$
 
(1)
The actual price to public and agent’s commissions for a particular investor may be reduced for volume purchase discounts depending on the aggregate amount of PLUS purchased by that investor.  The lowest price payable by an investor is $9.95 per PLUS.  Please see “Syndicate Information” on page 6 for further details.
(2)
For additional information, see “Plan of Distribution” in the prospectus supplement for PLUS.
 
YOU SHOULD READ THIS DOCUMENT TOGETHER WITH THE RELATED PROSPECTUS SUPPLEMENT AND PROSPECTUS, EACH OF WHICH CAN BE ACCESSED VIA THE HYPERLINKS BELOW, BEFORE YOU DECIDE TO INVEST.
 
 
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.
 
FWP: MSPRB1007001


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
Investment Overview
 
Performance Leveraged Upside Securities
The iShares® MSCI Emerging Markets Index Fund PLUS (the “PLUS”) can be used:
 
§
As an alternative to direct exposure to the underlying shares that enhances returns for a certain range of price performance of shares of the underlying shares.
 
§
To enhance returns and potentially outperform the underlying shares in a moderately bullish scenario
 
§
To achieve similar levels of exposure to the underlying shares as a direct investment while using fewer dollars by taking advantage of the leverage factor
 
The PLUS are exposed on a 1:1 basis to the negative performance of the underlying shares.
 
 
Maturity:
13 Months
 
Leverage factor:
300%
 
Maximum payment at maturity:
$12.60 to $12.80 (126% to 128% of the stated principal amount)
 
Principal protection:
None
 
iShares® MSCI Emerging Markets Index Fund Overview
 
The iShares® MSCI Emerging Markets Index Fund is an exchange-traded fund managed by iShares®, Inc., a registered investment company, which seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Emerging Markets Index. The MSCI Emerging Markets Index is a stock index calculated, published and disseminated daily by MSCI Inc. (“MSCI”), a majority-owned subsidiary of Morgan Stanley, and is designed to measure equity market performance in the global emerging markets.
 
Information as of market close on April 21, 2008:
 
 
Bloomberg Ticker Symbol:
EEM
 
Current Share Price:
$146.66
 
52 Weeks Ago:
$122.51
 
52 Week High (on 10/31/07):
$167.19
 
52 Week Low (on 8/16/07):
$118.50

Underlying Shares Historical Performance –
Daily Closing Prices
April 11, 2003 to April 21, 2008
 
 
May 2008
Page 2


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
Key Investment Rationale
 
This 13 month investment offers 300% leveraged upside, subject to a maximum payment at maturity of $12.60 to $12.80 (126% to 128% of the stated principal amount).
 
Investors can use the PLUS to enhance returns up to the maximum payment at maturity, while maintaining similar risk as a direct investment in the underlying shares.
 
Leverage
Performance
The PLUS offer investors an opportunity to capture enhanced returns relative to a direct investment in the underlying shares within a certain range of price performance.
Best Case Scenario
The underlying shares increase in price and, at maturity, the PLUS redeem for the maximum payment at maturity of $12.60 to $12.80 (126% to 128% of the stated principal amount).
Worst Case Scenario
The underlying shares decline in price and, at maturity, the PLUS redeem for less than the stated principal amount by an amount proportional to the decline.
 
Summary of Selected Key Risks (see page 9)
 
§
No guaranteed return of principal.
 
§
No interest payments.
 
§
Appreciation potential is limited by the maximum payment at maturity.
 
§
The MSCI Emerging Markets Index® is subject to currency exchange risk.
 
§
There are risks associated with investments in securities linked solely to the value of emerging markets equity securities.
 
§
Investing in the PLUS is not equivalent to investing in the underlying shares.
 
§
Adjustments to the underlying shares or to the MSCI Emerging Markets Index® could adversely affect the PLUS.
 
§
The underlying shares may not exactly track the MSCI Emerging Markets Index®.
 
§
The antidilution adjustments do not cover every event that could affect the underlying shares.
 
§
Secondary trading may be limited, and the inclusion of commissions and projected profit from hedging in the original issue price is likely to adversely affect secondary market prices and you could receive less, and possibly significantly less, than the stated principal amount per PLUS if you try to sell your PLUS prior to maturity.
 
§
The market price of the PLUS will be influenced by many unpredictable factors, including the value, volatility and dividend yield of the MSCI Emerging Markets Index®.
 
§
The U.S. federal income tax consequences of an investment in the PLUS are uncertain.
 
§
Credit risk to Morgan Stanley.
 
 
May 2008
Page 3


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
Fact Sheet
 
The PLUS offered are senior unsecured obligations of Morgan Stanley, will pay no interest, do not guarantee any return of principal at maturity and have the terms described in the prospectus supplement for PLUS and the prospectus, as supplemented or modified by these preliminary terms.  At maturity, an investor will receive for each stated principal amount of PLUS that the investor holds, an amount in cash that may be more or less than the stated principal amount based upon the closing price of one underlying share at maturity.  The PLUS are senior notes issued as part of Morgan Stanley’s Series F Global Medium-Term Notes program.

Expected Key Dates
   
Pricing Date:
Original Issue Date (Settlement Date):
Maturity Date:
May    , 2008
May       , 2008 (5 business days after the pricing date)
June 20, 2009, subject to postponement due to a market disruption event
Key Terms
 
Issuer:
Morgan Stanley
Underlying shares:
Shares of the iShares® MSCI Emerging Markets Index Fund
$10 per PLUS (see “Syndicate Information” on page 6)
Aggregate principal amount:
$
Stated principal amount:
$10 per PLUS
Denominations:
$10 per PLUS and integral multiples thereof
Interest:
None
Bull market or bear market PLUS:
Bull market PLUS
Payment at maturity:
§  If the final share price is greater than the initial share price,
 
$10 + leveraged upside payment
 
In no event will the payment at maturity exceed the maximum payment at maturity
 
§  If the final share price is less than or equal to the initial share price,
 
$10 x share performance factor
 
This amount will be less than or equal to the stated principal amount of $10.
Leveraged upside payment:
$10  x  leverage factor  x  share percent increase
Leverage factor:
300%
Share percent increase:
(final share price – initial share price) / initial share price
Initial share price:
The closing price of one underlying share on the pricing date published under the Bloomberg ticker symbol “EEM” or any successor symbol
Final share price:
The closing price of the one underlying share on the valuation date published under the Bloomberg ticker symbol “EEM” or any successor symbol
Valuation date:
June 18, 2009, subject to adjustment for certain market disruption events
Share performance factor:
(final share price / initial share price)
Maximum payment at maturity:
$12.60 to $12.80 (126% to 128% of the stated principal amount)
Adjustment factor:
1.0, subject to adjustment in the event of certain events affecting the underlying shares.
Postponement of
maturity date:
If the scheduled valuation date is not a trading day or if a market disruption event occurs on that day so that the valuation date as postponed falls less than two scheduled trading days prior to the scheduled maturity date, the maturity date of the PLUS will be postponed until the second scheduled trading day following that valuation date as postponed.
Risk factors:
Please see “Risk Factors” on page 9.
 
 
May 2008
Page 4


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
General Information
 
Listing:
The PLUS will not be listed on any securities exchange.
CUSIP:
617480322
Minimum ticketing size:
100 PLUS
Tax considerations:
Although the issuer believes that, under current law, the PLUS should be treated as a single financial contract that is an “open transaction” for U.S. federal income tax purposes, there is uncertainty regarding the U.S. federal income tax consequences of an investment in the PLUS.
 
Assuming this characterization of the PLUS is respected and subject to the discussion in “United States Federal Taxation” in the accompanying prospectus supplement for PLUS, the following U.S. federal income tax consequences should result based on current law:
 
§  A U.S. Holder (as defined in the accompanying prospectus supplement) should not be required to recognize taxable income over the term of the PLUS prior to maturity, other than pursuant to a sale or exchange.
 
§  Upon sale, exchange or settlement of the PLUS at maturity, a U.S. Holder should generally recognize gain or loss equal to the difference between the amount realized and the U.S. Holders tax basis in the PLUS.  Subject to the discussion below concerning the potential application of the “constructive ownership” rule under Section 1260 of the Internal Revenue Code of 1986, as amended, any capital gain or loss recognized upon sale, exchange or settlement of a PLUS should be long-term capital gain or loss if the U.S. Holder has held the PLUS for more than one year at such time.
 
As discussed in the accompanying prospectus supplement under “United States Federal Taxation ─ Tax Consequences to U.S. Holders ─ Tax Treatment of the PLUS ─ Possible Application of Section 1260 of the Code,” although the matter is not clear, there is a substantial risk that an investment in the PLUS will be treated as a “constructive ownership transaction.”  If this treatment applies, it is not clear to what extent any long-term capital gain of the U.S. Holder in respect of the PLUS will be recharacterized as ordinary income (which ordinary income would also be subject to an interest charge).  U.S. investors should consult their tax advisers regarding the potential application of the “constructive ownership” rule.
 
On December 7, 2007, the Treasury Department and the Internal Revenue Service (“IRS”) released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments, such as the PLUS.  The notice focuses in particular on whether to require holders of these instruments to accrue income over the term of their investment.  It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” regime.  While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the PLUS, possibly with retroactive effect.  Both U.S. and Non-U.S. Holders (as defined in the accompanying prospectus supplement) should consult their tax advisers regarding the U.S. federal income tax consequences of an investment in the PLUS, including possible alternative treatments, the potential application of the constructive ownership regime and the issues presented by this notice.
 
Both U.S. and non-U.S. investors considering an investment in the PLUS should read the discussion under “Risk Factors ― Structure Specific Risk Factors” in this document and the discussion under “United States Federal Taxation” in the accompanying prospectus supplement for PLUS and consult their tax advisers regarding the U.S. federal income tax consequences of investing in the PLUS as well as the notice described above and its potential implications for an investment in the PLUS.
Trustee:
The Bank of New York (as successor trustee to JPMorgan Chase Bank, N.A.)
Calculation agent:
Morgan Stanley & Co. Incorporated (“MS & Co.”)
Use of proceeds and hedging:
The net proceeds we receive from the sale of the PLUS will be used for general corporate purposes and, in part, in connection with hedging our obligations under the PLUS through one or more of our subsidiaries.
 
 
May 2008
Page 5


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
 
On or prior to the pricing date, we, through our subsidiaries or others, will hedge our anticipated exposure in connection with the PLUS by taking positions in the underlying shares and in futures and options contracts on the underlying shares and the component stocks of the MSCI Emerging Markets Index.  Such purchase activity could increase the price of the underlying shares, and therefore the price at which the underlying shares must close on the valuation date before investors would receive at maturity a payment that exceeds the principal amount of the PLUS.  For further information on our use of proceeds and hedging, see “Use of Proceeds and Hedging” in the prospectus supplement for PLUS.
ERISA:
See “ERISA” in the prospectus supplement for PLUS.
Contact:
Morgan Stanley clients may contact their local Morgan Stanley branch office or our principal executive offices at 1585 Broadway, New York, New York 10036 (telephone number (866) 477-4776).  All other clients may contact their local brokerage representative.  Third-party distributors may contact Morgan Stanley Structured Investment Sales at (800) 233-1087.

Syndicate Information
   
Issue price of the PLUS
Selling concession
Principal amount of PLUS for any single investor
$10.00
$0.15
<$999K
$9.975
$0.125
$1MM-$2.99MM
$9.9625
$0.1125
$3MM-$4.99MM
$9.95
$0.10
>$5MM

 
Selling concessions allowed to dealers in connection with the offering may be reclaimed by the agent, if, within 30 days of the offering, the agent repurchases the PLUS distributed by such dealers.
 
This offering summary represents a summary of the terms and conditions of the PLUS.  We encourage you to read the accompanying prospectus supplement for PLUS and prospectus related to this offering, which can be accessed via the hyperlinks on the front page of this document.
 
 
May 2008
Page 6


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
How PLUS Work
 
Payoff Diagram
The payoff diagram below illustrates the payment at maturity on the PLUS based on the following hypothetical terms:
 
 
Stated principal amount:
$10
 
Leverage factor:
300%
 
Hypothetical maximum payment at maturity:
$12.70 (127% of the stated principal amount)
 
PLUS Payoff Diagram
 
How it works
 
§
If the final share price is greater than the initial share price, then investors receive the $10 stated principal amount plus 300% of the appreciation of the underlying shares over the term of the PLUS, subject to the hypothetical maximum payment at maturity.  In the payoff diagram, an investor will realize the hypothetical maximum payment at maturity at a final share price of approximately 109% of the initial share price.
 
 
§
If the underlying shares appreciate 5%, the investor would receive a 15% return, or $11.50.
 
 
§
If the underlying shares appreciate 25%, the investor would receive the hypothetical maximum payment at maturity of 127% of the stated principal amount, or $12.70.
 
§
If the final share price is less than or equal to the initial share price, the investor would receive an amount less than or equal to the $10 stated principal amount, based on a 1% loss of principal for each 1% decline in the price of the underlying shares.
 
 
§
If the underlying shares depreciate 10%, the investor would lose 10% of its principal and receive only $9 at maturity, or 90% of the stated principal amount.
 
 
May 2008
Page 7


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
Payment at Maturity
 
At maturity, investors will receive for each $10 stated principal amount of PLUS that they hold an amount in cash based upon the price of the underlying shares, determined as follows:
 
If the final share price is greater than the initial share price:
 
$10    +    Leveraged Upside Payment:
 
subject to the maximum payment at maturity for each PLUS,
 
 
If the final share price is less than or equal to the initial share price:
 
$10    x    Share Performance Factor
 
 
Because the share performance factor will be less than or equal to 1.0, this payment will be less than or equal to $10.
 
 
May 2008
Page 8


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
 
The following is a non-exhaustive list of certain key risk factors for investors in the PLUS.  For further discussion of these and other risks, you should read the section entitled “Risk Factors” beginning on page S-18 of the prospectus supplement for PLUS.  We also urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the PLUS.
 
Structure Specific Risk Factors
 
§
PLUS do not pay interest nor guarantee return of principal. The terms of the PLUS differ from those of ordinary debt securities in that the PLUS do not pay interest nor guarantee payment of the principal amount at maturity.  If the final share price is less than the initial share price, the payout at maturity will be an amount in cash that is less than the $10 stated principal amount of each PLUS by an amount proportionate to the decrease in the price of the underlying shares.
 
§
Appreciation potential is limited.  The appreciation potential of PLUS is limited by the maximum payment at maturity of $12.60 to $12.80 (126% to 128% of the stated principal amount).  Although the leverage factor provides 300% exposure to any increase in the price of the underlying shares at maturity, because the payment at maturity will be limited to 126% to 128% of the stated principal amount for the PLUS, the percentage exposure provided by the leverage factor is progressively reduced as the final share price exceeds approximately 108.667% to approximately 109.333% of the initial share price.
 
§
Market price influenced by many unpredictable factors. Several factors will influence the value of the PLUS in the secondary market and the price at which MS & Co. may be willing to purchase or sell the PLUS in the secondary market, including: the value, volatility and dividend yield of the MSCI Emerging Markets Index, interest and yield rates, time remaining to maturity, geopolitical conditions and economic, financial, political and regulatory or judicial events and creditworthiness of the issuer.
 
§
The price of the underlying shares is subject to currency exchange risk.  Because the price of the underlying shares is related to the U.S. dollar value of stocks underlying the MSCI Emerging Markets Index Fund, holders of the PLUS will be exposed to currency exchange rate risk with respect to each of the emerging markets currencies in which such component securities trade.  Exchange rate movements for a particular currency are volatile and are the result of numerous factors specific to that country including the supply of, and the demand for, those currencies, as well as government policy, intervention or actions, but are also influenced significantly from time to time by political or economic developments, and by macroeconomic factors and speculative actions related to each region.  Currencies of emerging economies are often subject to more frequent and larger central bank interventions than the currencies of developed countries and are also more likely to be affected by drastic changes in monetary or exchange rate policies of the relevant country.  An investor’s net exposure will depend on the extent to which the currencies of the component countries strengthen or weaken against the U.S. dollar and the relative weight of each currency.  If, taking into account such weighting, the dollar strengthens against the currencies of the component securities represented in the MSCI Emerging Markets Index, the price of the underlying shares will be adversely affected and the payment at maturity on the PLUS may be reduced.
 
Of particular importance to potential currency exchange risk are:
 
 
§
existing and expected rates of inflation;
 
 
§
existing and expected interest rate levels;
 
 
§
the balance of payments; and
 
 
§
the extent of governmental surpluses or deficits in the component countries and the United States of America.
 
All of these factors are in turn sensitive to the monetary, fiscal and trade policies pursued by the governments of various component countries and the United States and other countries important to international trade and finance.
 
 
May 2008
Page 9


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
§
There are risks associated with investments in securities linked to the value of emerging markets equity securities.  The stocks included in the MSCI Emerging Markets Index and that are generally tracked by the underlying shares have been issued by companies in various emerging markets countries.  Investments in securities linked to the value of emerging markets equity securities involve risks associated with the securities markets in those countries, including risks of volatility in those markets, governmental intervention in those markets and cross-shareholdings in companies in certain countries.  Also, there is generally less publicly available information about foreign companies than about U.S. companies that are subject to the reporting requirements of the United States Securities and Exchange Commission, and foreign companies are subject to accounting, auditing and financial reporting standards and requirements different from those applicable to U.S. reporting companies.  The prices of securities in emerging markets may be affected by political, economic, financial and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws.
 
The prices of securities in emerging markets may be affected by political, economic, financial and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws.  Countries with emerging markets may have relatively unstable governments, may present the risks of nationalization of businesses, restrictions on foreign ownership and prohibitions on the repatriation of assets, and may have less protection of property rights than more developed countries. The economies of countries with emerging markets may be based on only a few industries, may be highly vulnerable to changes in local or global trade conditions, and may suffer from extreme and volatile debt burdens or inflation rates. Local securities markets may trade a small number of securities and may be unable to respond effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or impossible at times.  Moreover, the economies in such countries may differ favorably or unfavorably from the economy in the United States in such respects as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.
 
§
Adjustments to the underlying shares or to the MSCI Emerging Markets Index could adversely affect the value of the PLUS.  Barclays Global Fund Advisors, which we refer to as BGFA, is the investment adviser to the iShares® MSCI Emerging Markets Index Fund, which seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Emerging Markets Index.  MSCI, Inc. (“MSCI”) is responsible for calculating and maintaining the MSCI Emerging Markets Index.  MSCI can add, delete or substitute the stocks underlying the MSCI Emerging Markets Index or make other methodological changes that could change the value of the MSCI Emerging Markets Index.  Pursuant to its investment strategy or otherwise, BGFA may add, delete or substitute the stocks composing the iShares® MSCI Emerging Markets Index Fund.  Any of these actions could adversely affect the price of the underlying shares and, consequently, the value of the PLUS.
 
§
Not equivalent to investing in the underlying shares. Investing in the PLUS is not equivalent to investing in the underlying shares or the MSCI Emerging Markets Index.  Investors in the PLUS will not have voting rights or rights to receive dividends or other distributions or any other rights with respect to the underlying shares or the stocks that constitute the MSCI Emerging Markets Index.
 
§
The underlying shares and the MSCI Emerging Markets Index are different. The performance of the underlying shares may not exactly replicate the performance of the MSCI Emerging Markets Index because the iShares® MSCI Emerging Markets Index Fund will reflect transaction costs and fees that are not included in the calculation of the MSCI Emerging Markets Index.  It is also possible that the iShares® MSCI Emerging Markets Index Fund may not fully replicate or may in certain circumstances diverge significantly from the performance of the MSCI Emerging Markets Index due to the temporary unavailability of certain securities in the secondary market, the performance of any derivative instruments contained in this fund, differences in trading hours between the iShares® MSCI Emerging Markets Index Fund and the MSCI Emerging Markets Index or due to other circumstances.  BGFA may invest up to 10% of the iShares® MSCI Emerging Markets Index Fund’s assets in shares of other iShares® funds that seek to track the performance of equity securities of constituent countries of the MSCI Emerging Markets Index.
 
§
The antidilution adjustments the calculation agent is required to make do not cover every event that could affect the underlying shares.  MS & Co., as calculation agent, will adjust the amount payable at maturity for certain events affecting the underlying shares.  However, the calculation agent will not make an adjustment for
 
 
May 2008
Page 10


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
every event that could affect the underlying shares.  If an event occurs that does not require the calculation agent to adjust the amount payable at maturity, the market price of the PLUS may be materially and adversely affected.
 
§
The inclusion of commissions and projected profit from hedging in the original issue price is likely to adversely affect secondary market prices.  Assuming no change in market conditions or any other relevant factors, the price, if any, at which MS & Co. is willing to purchase PLUS in secondary market transactions will likely be lower than the original issue price, since the original issue price included, and secondary market prices are likely to exclude, commissions paid with respect to the PLUS, as well as the projected profit included in the cost of hedging the issuer’s obligations under the PLUS.  In addition, any such prices may differ from values determined by pricing models used by MS & Co., as a result of dealer discounts, mark-ups or other transaction costs.
 
§
The U.S. federal income tax consequences of an investment in the PLUS are uncertain.  Please read the discussion under “Fact Sheet General Information Tax Considerations” in this document and the discussion under “United States Federal Taxation” in the accompanying prospectus supplement for PLUS (together the “Tax Disclosure Sections”) concerning the U.S. federal income tax consequences of investing in the PLUS.  If the IRS were successful in asserting an alternative characterization or treatment, the timing and character of income on the PLUS might differ significantly from the tax treatment described in the Tax Disclosure Sections.  For example, as discussed in the Tax Disclosure Sections, there is a substantial risk that the “constructive ownership” rule could apply, in which case all or a portion of any long-term capital gain recognized by a U.S. Holder might be recharacterized as ordinary income (which ordinary income would also be subject to an interest charge).  Under another characterization, U.S. Holders could be required to accrue original issue discount on the PLUS every year at a “comparable yield” determined at the time of issuance and recognize all income and gain in respect of the PLUS as ordinary income.  The issuer does not plan to request a ruling from the IRS regarding the tax treatment of the PLUS, and the IRS or a court may not agree with the tax treatment described in this document and the accompanying prospectus supplement.
 
On December 7, 2007, the Treasury Department and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments, such as the PLUS.  The notice focuses in particular on whether to require holders of these instruments to accrue income over the term of their investment.  It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” regime.  While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the PLUS, possibly with retroactive effect.  Both U.S. and Non-U.S. Holders should consult their tax advisers regarding the U.S. federal income tax consequences of an investment in the PLUS, including possible alternative treatments, the potential application of the constructive ownership regime and the issues presented by this notice.
 
Other Risk Factors
 
§
Secondary trading may be limited.  The PLUS will not be listed on any securities exchange and secondary trading may be limited, and the inclusion of commissions and projected profit from hedging in the original issue price is likely to adversely affect secondary market prices and you could receive less, and possibly significantly less, than the stated principal amount per PLUS if you try to sell your PLUS prior to maturity.
 
§
Potential adverse economic interest of the calculation agent. The hedging or trading activities of the issuer’s affiliates on or prior to the pricing date and prior to maturity could adversely affect the price of the underlying shares and, as a result, could decrease the amount an investor may receive on the PLUS at maturity.  Any of these hedging or trading activities on or prior to the pricing date could potentially affect the initial share price and, therefore, could increase the price at which the underlying shares must close before an investor receives a payment at maturity that exceeds the issue price of the PLUS.  Additionally, such hedging or trading activities during the term of the PLUS, including on the valuation date, could potentially affect the price of the underlying shares on the valuation date and, accordingly, the amount of cash an investor will receive at maturity.
 
 
May 2008
Page 11


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
Information about the Underlying Shares
 
The iShares® MSCI Emerging Markets Index Fund
The iShares® MSCI Emerging Markets Index Fund is an exchange-traded fund managed by iShares®, Inc. (“iShares”), a registered investment company.  iShares consists of numerous separate investment portfolios, including the iShares® MSCI Emerging Markets Index Fund.   This fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Emerging Markets Index®.  Information provided to or filed with the Commission by iShares pursuant to the Securities Act of 1933 and the Investment Company Act of 1940 can be located by reference to Commission file numbers 033-97598 and 811-09102, respectively, through the Commission’s website at http://www.sec.gov.  In addition, information may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents.  We make no representation or warranty as to the accuracy or completeness of such information.
 
These preliminary terms relate only to the PLUS offered hereby and does not relate to the underlying shares.  We have derived all disclosures contained in these preliminary terms regarding iShares from the publicly available documents described in the preceding paragraph.  In connection with the offering of the PLUS, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to iShares.  Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding iShares is accurate or complete.  Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described in the preceding paragraph) that would affect the trading price of the underlying shares (and therefore the price of the underlying shares at the time we priced the PLUS) have been publicly disclosed.  Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning iShares could affect the value received at maturity with respect to the PLUS and therefore the trading prices of the PLUS.
 
Neither we nor any of our affiliates makes any representation to you as to the performance of the underlying shares.
 
We and/or our affiliates may presently or from time to time engage in business with iShares.  In the course of such business, we and/or our affiliates may acquire non-public information with respect to iShares, and neither we nor any of our affiliates undertakes to disclose any such information to you.  In addition, one or more of our affiliates may publish research reports with respect to the underlying shares.  The statements in the preceding two sentences are not intended to affect the rights of investors in the PLUS under the securities laws.  As a prospective purchaser of the PLUS, you should undertake an independent investigation of iShares as in your judgment is appropriate to make an informed decision with respect to an investment in the underlying shares.
 
iShares® is a registered mark of Barclays Global Investors, N.A. (“BGI”).    The PLUS are not sponsored, endorsed, sold, or promoted by BGI.  BGI makes no representations or warranties to the owners of the PLUS or any member of the public regarding the advisability of investing in the PLUS.  BGI has no obligation or liability in connection with the operation, marketing, trading or sale of the PLUS.
 
The MSCI Emerging Markets Index®
The MSCI Emerging Markets Index is calculated, published and disseminated daily by MSCI, a majority-owned subsidiary of Morgan Stanley, and comprises the equity securities underlying the MSCI indices of 25 selected emerging market countries.   See “Annex A—Underlying Indices and Underlying Index Publishers Information—The MSCI Emerging Markets Index®” in the accompanying prospectus supplement for PLUS.
 
 
May 2008
Page 12


PLUS based on the iShares® MSCI Emerging Markets Index Fund due June 20, 2009
Performance Leveraged Upside SecuritiesSM

 
Historical Information
The following table presents the published high, low and end-of-quarter closing share prices for each quarter in the period from April 11, 2003 through April 21, 2008.  The closing share price on April 21, 2008 was $146.66.  The issuer obtained the closing share prices and other information below from Bloomberg Financial Markets, without independent verification.  You should not take the historical closing share prices as an indication of future performance.
 
iShares® MSCI Emerging Markets Index Fund
High
Low
Period End
2003
     
Second Quarter (beginning April 11, 2003)
40.87
33.23
39.97
Third Quarter
47.66
40.40
45.31
Fourth Quarter
54.64
46.50
54.64
2004
     
First Quarter
59.51
55.15
58.50
Second Quarter
60.61
47.65
53.88
Third Quarter
57.50
50.89
57.50
Fourth Quarter
67.28
56.70
67.28
2005
     
First Quarter
73.95
63.63
67.60
Second Quarter
73.11
65.10
71.60
Third Quarter
85.02
71.83
84.88
Fourth Quarter
89.50
75.15
88.25
2006
     
First Quarter
100.78
91.55
99.00
Second Quarter
111.10
81.95
93.90
Third Quarter
99.30
87.60
96.77
Fourth Quarter
114.60
95.30
114.17
2007
     
First Quarter
118.63
105.29
116.50
Second Quarter
133.20
117.45
131.65
Third Quarter
150.40
118.50
149.45
Fourth Quarter
167.19
141.53
150.30
2008
     
First Quarter
151.10
126.47
134.38
Second Quarter (through April 21, 2008)
146.66
139.01
146.66
 

 
May 2008
Page 13